Detalhe da pesquisa
1.
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort.
Rheumatology (Oxford)
; 63(2): 472-481, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228011
2.
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552315
3.
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
Am J Respir Crit Care Med
; 205(6): 674-684, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34851799
4.
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.
Arthritis Res Ther
; 24(1): 133, 2022 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659282
5.
Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.
Eur Heart J
; 31(17): 2111-23, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20513729
6.
The effect of a combination of gabapentin and donepezil in an experimental pain model in healthy volunteers: Results of a randomized controlled trial.
Pain
; 155(12): 2510-2516, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25218827
7.
Combined NK1 antagonism and serotonin reuptake inhibition: effects on emotional processing in humans.
J Psychopharmacol
; 27(5): 435-43, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23407644
8.
The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects.
J Clin Pharmacol
; 53(10): 1078-90, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23934621